1. A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study. (September 2013) Authors: Greenberg, Eyal; Besser, Michal J.; Ben-Ami, Eytan; Shapira-Frommer, Ronnie; Itzhaki, Orit; Zikich, Dragoslav; Levy, Daphna; Kubi, Adva; Eyal, Eran; Onn, Amir; Cohen, Yehudit; Barshack, Iris; Schachter, Jacob; Markel, Gal Journal: Biomarkers Issue: Volume 18:Number 6(2013) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Direct Electrochemical Detection Method of Melanoma Based on Melanoma Biomarker. Issue 8 (9th July 2014) Authors: Mossberg, Michal; Vernick, Sefi; Ortenberg, Rona; Markel, Gal; Diamand, Yosi Shacham‐; Rishpon, Judith Journal: Electroanalysis Issue: Volume 26:Issue 8(2014:Aug.) Page Start: 1671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study. (October 2019) Authors: Bar, Jair; Markel, Gal; Gottfried, Teodor; Percik, Ruth; Leibowitz-Amit, Raya; Berger, Raanan; Golan, Talia; Daher, Sameh; Taliansky, Alisa; Dudnik, Elizabeth; Shulman, Katerina; Urban, Damien; Onn, Amir Journal: European journal of cancer Issue: Volume 120(2019) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adoptive Cell Therapy for Metastatic Melanoma. Issue 1 (January 2017) Authors: Merhavi-Shoham, Efrat; Itzhaki, Orit; Markel, Gal; Schachter, Jacob; Besser, Michal J. Journal: Cancer journal Issue: Volume 23:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adoptive T cell therapy: An overview of obstacles and opportunities. (1st June 2017) Authors: Baruch, Erez Nissim; Berg, Amy Lauren; Besser, Michal Judith; Schachter, Jacob; Markel, Gal Journal: Cancer Issue: Volume 123(2017)Supplement S11 Page Start: 2154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adoptive T-cell transfer in melanoma. (January 2013) Authors: Itzhaki, Orit; Levy, Daphna; Zikich, Dragoslav; Treves, Avraham J; Markel, Gal; Schachter, Jacob; Besser, Michal J Journal: Immunotherapy Issue: Volume 5:Number 1(2013:Jan.) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma. Issue 11 (November 2022) Authors: Meirson, Tomer; Neiman, Victoria; Sternschuss, Michal; Markel, Gal; Tannock, Ian F Journal: Lancet oncology Issue: Volume 23:Issue 11(2022) Page Start: e489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM. Survival Analysis From the Randomized Controlled Trial LIGRO" by K. Hasselgren, et al., Annals of Surgery 2020 The Jury is Still Out. Issue 6 (December 2021) Authors: Bomze, David; Markel, Gal; Meirson, Tomer; Azoulay, Daniel Journal: Annals of surgery Issue: Volume 274:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy. Issue 5 (14th May 2021) Authors: Nissani, Abraham; Lev-Ari, Shaked; Meirson, Tomer; Jacoby, Elad; Asher, Nethanel; Ben-Betzalel, Guy; Itzhaki, Orit; Shapira-Frommer, Ronnie; Schachter, Jacob; Markel, Gal; Besser, Michal J. Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response. Issue 7 (6th April 2020) Authors: Besser, Michal J.; Itzhaki, Orit; Ben‐Betzalel, Guy; Zippel, Douglas B.; Zikich, Dragoslav; Kubi, Adva; Brezinger, Karin; Nissani, Abraham; Levi, Michal; Zeltzer, Li‐at; Ben‐Nun, Alon; Asher, Nethanel; Shimoni, Avichai; Nagler, Arnon; Markel, Gal; Shapira‐Frommer, Ronnie; Schachter, Jacob Other Names: Lu Yong‐Chen guestEditor. Journal: Molecular carcinogenesis Issue: Volume 59:Issue 7(2020) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗